Loading clinical trials...
Loading clinical trials...
Phase II Study of Avastin Plus Erbitux Plus Irinotecan as 2nd Line Treatment of Locally Advanced or Metastatic Colorectal Cancer in Patients Achieving Disease Progression as Best Response After 1st Line Treatment With FOLFIRI+Avastin or XELIRI+Avastin
Conditions
Interventions
Irinotecan
Avastin
+1 more
Locations
8
Greece
University General Hospital of Alexandroupolis, Dep of Medical Oncology
Alexandroupoli, Greece
401 Military Hospital of Athens
Athens, Greece
: "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine
Athens, Greece
Air Forces Military Hospital of Athens
Athens, Greece
IASO" General Hospital of Athens, 1st Dep of Medical Oncology
Athens, Greece
State General Hospital of Larissa
Larissa, Greece
Start Date
April 1, 2008
Primary Completion Date
February 1, 2010
Completion Date
February 1, 2010
Last Updated
February 13, 2013
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
Hellenic Oncology Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions